Atlas FDA

Organ Care System (OCS™) Liver

FDA premarket approval P200031 · decided 2021-09-28

Approval details

PMA number
P200031
Trade name
Organ Care System (OCS™) Liver
Generic name
Normothermic machine perfusion system for the preservation of donor livers prior to transplantation
Applicant
TransMedics, Inc.
Date received
2020-06-30
Decision date
2021-09-28
Days to decision
455 days
Decision code
APPR
Product code
QQK
Advisory committee
Gastroenterology, Urology
Expedited review
No
Location
Andover, MA
Statement
Approval for Organ Care System (OCS) Liver for the indication of: The TransMedics® Organ Care System (OCS) Liver is a portable extracorporeal liver perfusion and monitoring system indicated for preservation and monitoring of hemodynamics and metabolic function which allows for ex-vivo assessment of liver allografts from donors after brain death (DBD) or liver allografts from donors after circulatory death (DCD) <=55 years old and with <=30 mins of warm ischemic time, macrosteatosis <=15%, in a n

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
OCS Heart Leukocyte Depleting Filter (K231362)TransMedics, Inc.2023-10-31
OCS Lung Donor Flush Set (K222535)TransMedics, Inc.2022-11-18
OCS Lung Solution (K211314)TransMedics, Inc.2021-07-29